Raphael Pharmaceutical Inc. — All Filings
173 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
3
3/A
4
4/A
424B3
5
8-A12G
8-K
8-K/A
CORRESP
DEF 14C
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14C
REGDEX
REVOKED
RW
S-1
S-1/A
SB-2
SB-2/A
SC 13D
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-26-033507 | Mar 24, 2026 | Dec 31, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-109968 | Nov 13, 2025 | Sep 30, 2025 |
| 3 | OWNERSHIP DOCUMENT | 0001213900-25-085537 | Sep 8, 2025 | Aug 1, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-075662 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-074293 | Aug 11, 2025 | Jul 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-073909 | Aug 11, 2025 | Aug 7, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-043641 | May 15, 2025 | Mar 31, 2025 |
| 10-K | ANNUAL REPORT | 0001213900-25-026214 | Mar 31, 2025 | Dec 31, 2024 |
| 4 | — | 0001213900-25-023367 | Mar 12, 2025 | May 12, 2022 |
| 4 | — | 0001213900-25-022736 | Mar 11, 2025 | Mar 2, 2025 |
| 4 | — | 0001213900-25-021172 | Mar 6, 2025 | Mar 5, 2025 |
| 3 | — | 0001213900-25-013687 | Feb 13, 2025 | Jan 8, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-003401 | Jan 14, 2025 | Jan 8, 2025 |
| 8-K | CURRENT REPORT | 0001213900-24-113467 | Dec 30, 2024 | Dec 23, 2024 |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-100968 | Nov 21, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-098456 | Nov 14, 2024 | Sep 30, 2024 |
| EFFECT | — | 9999999995-24-002976 | Sep 26, 2024 | — |
| CORRESP | — | 0001213900-24-081436 | Sep 24, 2024 | — |
| UPLOAD | — | 0000000000-24-010774 | Sep 23, 2024 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-24-078562 | Sep 13, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-077706 | Sep 11, 2024 | Sep 5, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-067723 | Aug 12, 2024 | Jun 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-056191 | Jun 26, 2024 | — |
| DEF 14C | INFORMATION STATEMENT | 0001213900-24-049686 | Jun 4, 2024 | — |
| PRE 14C | INFORMATION STATEMENT | 0001213900-24-046277 | May 23, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-043557 | May 15, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0001213900-24-039106 | May 2, 2024 | Apr 30, 2024 |
| 10-K | ANNUAL REPORT | 0001213900-24-027234 | Mar 28, 2024 | Dec 31, 2023 |
| 4 | — | 0001213900-24-025520 | Mar 25, 2024 | Nov 25, 2023 |
| 4 | — | 0001213900-24-025519 | Mar 25, 2024 | Aug 29, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-086894 | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-065005 | Aug 9, 2023 | Jun 30, 2023 |
| EFFECT | — | 9999999995-23-001732 | Jun 13, 2023 | — |
| EFFECT | — | 9999999995-23-001729 | Jun 13, 2023 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 | 0001213900-23-044792 | Jun 1, 2023 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 | 0001213900-23-044791 | Jun 1, 2023 | — |
| 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-23-043104 | May 25, 2023 | Dec 31, 2022 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-039833 | May 15, 2023 | Mar 31, 2023 |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 | 0001213900-23-036405 | May 4, 2023 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001213900-23-035523 | May 2, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-023667 | Mar 28, 2023 | Mar 27, 2023 |
| 10-K | ANNUAL REPORT | 0001213900-23-022628 | Mar 24, 2023 | Dec 31, 2022 |
| 4 | — | 0001213900-23-019558 | Mar 13, 2023 | Dec 5, 2022 |
| 4 | — | 0001213900-23-019557 | Mar 13, 2023 | Dec 5, 2022 |
| 4 | — | 0001213900-23-019556 | Mar 13, 2023 | Jul 26, 2022 |
| 4 | — | 0001213900-23-019554 | Mar 13, 2023 | Dec 5, 2022 |
| 4 | — | 0001213900-23-019553 | Mar 13, 2023 | Jul 26, 2022 |
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-23-005219 | Jan 26, 2023 | Jul 7, 2022 |
| 10-Q | QUARTERLY REPORT | 0001213900-22-071861 | Nov 14, 2022 | Sep 30, 2022 |
| 8-K | CURRENT REPORT | 0001213900-22-065828 | Oct 24, 2022 | Oct 7, 2022 |